Contribution of obesity to left atrial and left ventricular dysfunction in asymptomatic patients with hypertension: A

Hirokazu Miyoshi1, Yoshifumi Oishi1, Yukio Mizuguchi1

  • 1Cardiovascular Section, Higashi Tokushima Medical Center, National Hospital Organization, Tokushima, Japan.

Insights

Obesity accelerates heart dysfunction in hypertensive patients. Two-dimensional speckle-tracking echocardiography reveals impaired left atrial-left ventricular interaction, highlighting obesity

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Imaging

Background:

  • Hypertension and obesity are known contributors to heart failure with preserved ejection fraction.
  • Understanding the impact of obesity on left atrial-left ventricular (LA-LV) interaction in hypertensive patients is clinically significant.
  • Asymptomatic patients with hypertension and obesity require further investigation into cardiac function deterioration.

Purpose of the Study:

  • To clarify the mechanisms of LA-LV interaction deterioration in asymptomatic hypertensive patients with obesity.
  • To assess the influence of obesity on cardiac function in the presence of hypertension.
  • To evaluate the utility of two-dimensional speckle-tracking echocardiography (2DSTE) in detecting subclinical cardiac changes.

Main Methods:

  • 134 asymptomatic hypertensive patients were studied using conventional and 2DSTE.
  • Patients were categorized into non-obese (BMI <25 kg/m²) and obese (BMI ≥25 kg/m²) groups.
  • Analysis focused on parameters including end-diastolic LV diameter, E/e', peak systolic LV strain rates, and LA strain (S-LAs).

Main Results:

  • The obese group exhibited greater end-diastolic LV diameter, E/e', peak systolic LV circumferential strain rate, and E/e'/S-LAs.
  • Multivariate analysis identified Body Mass Index (BMI) as independently associated with end-diastolic LV diameter and peak systolic LV radial strain in all patients.
  • In obese patients, age, systolic blood pressure, relative LV wall thickness, s', peak systolic LV radial strain, and peak early diastolic LV longitudinal strain rate independently predicted E/e'/S-LAs; in non-obese patients, only s' was a predictor.

Conclusions:

  • Obesity accelerates impaired LA-LV interaction in hypertensive individuals.
  • 2DSTE provides valuable insights into the detrimental effects of cardiovascular risk factors on LA and LV function in asymptomatic patients.
  • Early detection of cardiac dysfunction using advanced echocardiographic techniques is crucial for managing hypertensive and obese populations.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891